Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030. Pfizer Inc (NYSE: PFE) has closed a $43 billion deal to acquire biotechnology...
Tag: Pfizer
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Pfizer will spend $43 billion to buy Seagen and deepen its reach into treating cancer. The pharmaceutical giant said Monday that it will pay $229 in cash for each Seagen share. Bothell, Washington-bas...
Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotech’s stock pops 20%
Pfizer Inc. PFE, -0.18% plans to acquire cancer biotechnology company Seagen Inc. SGEN, -0.59% in a deal with a $43 billion enterprise value, the companies announced Monday morning. Pfizer intends to ...
New ‘Fast-Acting’ Migraine Drug Approved By FDA
Topline The Food and Drug Administration on Friday approved a new nasal spray drug giant Pfizer says could offer “fast-acting relief” from migraines, launching a new form of medicine onto the market a...
Pfizer favored over Merck for Seagen acquisition: SVB analyst
Pfizer’s (PFE) interest in Seagen (SGEN) marks the second time in a year the cancer-focused biotech has been an acquisition target by a major pharmaceutical player in the cancer space. Seagen wa...
Novavax Says ‘Substantial Doubt’ Around Its Continuing Operations
Covid-19 vaccine manufacturer Novavax said Tuesday that there is “substantial doubt” about its ability to continue operating through this year. In a quarterly earnings report issued after the market c...
VitaDAO Closes $4.1M Funding Round With Pfizer Ventures for Longevity Research
VitaDAO was started in 2021 by Tyler Golato of decentralized biotech protocol Molecule to fund longevity research. According to the organization, it boasts a community of over 9,000 “enthusiasts...
Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.
Pfizer executives say Wall Street analysts haven’t understood just how powerful a hit the company’s Covid-19 products will take this year. That’s the explanation the company’s chief financial officer,...
Pfizer Loses $40 Billion of Value in Worst Month Since 2020
(Bloomberg) — Shares of Pfizer Inc. suffered their biggest monthly decline since June 2020 as investors anticipated a troubled path ahead for the drugmaker’s Covid products. Most Read from Bloom...
Pfizer (PFE) Q4 earnings 2022
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garri...
Decentralized project VitaDAO raises $4.1m from Pfizer, others
VitaDAO has secured $4.1 million in a token-based funding round led by Pfizer Ventures, with participation from Balaji Srinivasan, L1 Digital, and several others. VitaDAO is focused on bringing to lif...
Longevity Startup VitaDAO Raises $4.1m, Backed By Pfizer, Balaji Srinivasan
VitaDAO is developing drug assets as IP-NFTs VitaDAO, scientific illustration by Dani Bergey The web transformed life as we know it, allowing new ways of working, solving problems, and distributing cu...
Pfizer Ventures backs decentralized science startup in $4.1 million round
VitaDAO, a decentralized autonomous organization that funds research projects in the field of longevity science, closed a $4.1 million raise. The venture arm of Pfizer invested in the token rou...
With Pfizer Firmly in Value Territory, Here’s What Investors Are Missing
Investors have faced a conundrum in valuing companies that benefited from the Covid-19 pandemic. Pfizer’s (PFE) partnership with BioNTech (BNTX) in creating a vaccine, plus its antiviral, Paxlov...
Pfizer Facing Profit Drop After Record Year as COVID Vaccine Demand Fades
Drugmaker Pfizer (PFE) will see out the most lucrative year in its history with fourth-quarter results due early Tuesday and hope its 2023 guidance isn’t too much of a letdown amid diminished de...
Pfizer, Unum Group And Signature Bank
On 1/26/23, Pfizer, Unum Group, and Signature Bank will all trade ex-dividend for their respective upcoming dividends. Pfizer Inc will pay its quarterly dividend of $0.41 on 3/3/23, Unum Group will pa...
mRNA Covid Shots Safe And Effective In Children Ages 5-11, Large Study Finds—Though Vaccine Uptake Remains Low
Topline mRNA Covid vaccines, such as Pfizer and Moderna shots, are effective at preventing infection and severe illness and have low rates of serious side effects in young children, according to a stu...
Pfizer Stock Needs A ‘Covid Reset,’ According To One Analyst; Shares Dive
Pfizer stock fell Tuesday after a Wells Fargo analyst downgraded shares and said the drug giant needs a “Covid reset.” X Wells Fargo analyst Mohit Bansal downgraded Pfizer (PFE) shares to ...
Goldman, Pfizer, Cheesecake Factory, Alibaba and more
A Cheesecake Factory restaurant in Louisville, Kentucky. Andy Lyons | Getty Images Check out the companies making the biggest moves midday: Goldman Sachs — The bank slid more than 2% after reporting e...
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Pfizer Covid booster likely doesn’t carry seniors’ stroke risk: CDC
The Centers for Disease Control and Prevention on Friday said it is “very unlikely” the Pfizer omicron booster carries a risk of stroke for seniors after it launched an investigation into ...
Stocks Dip, Powell, Pfizer Oak Street, Microsoft-5 Things To Know
Five things you need to know before the market opens on Tuesday January 10: 1. — Stock Futures Slip Lower On Hawkish Fed Signals U.S. equity futures slipped lower Tuesday, extending a move from...
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September
Topline Trials of cutting-edge cancer vaccines could kick off in the U.K. as soon as September, German Covid vaccine maker BioNTech announced on Friday, part of a new government partnership to fast tr...
Pfizer Stock: How This ‘Covid Darling’ Became A ‘Show Me’ Story In 2023
Pfizer (PFE) stock tumbled Wednesday after an analyst downgraded it, saying the “Covid darling” is now a “show me” story as Comirnaty and Paxlovid sales crumble. X The pharmace...
Will Pfizer Share Price (NYSE: PFE) Sustain above $50? – Quarterly Growth Shines by 15%
Pfizer Share price has showcased some promising trading factors as it crossed 16% growth rate during this quarter. Pfizer Inc. (NYSE: PFE) is up 41% in the last five years, also slightly above the mar...